Literature DB >> 25628846

Inflammatory myofibroblastic tumor of salpinx: a very rare case treated with a less aggressive method.

Fatemeh Homaei-Shandiz1, Reza Jafarzadeh-Esfehani2, Nasrin Moazzen3, Amir Amirabadi4.   

Abstract

Inflammatory pseudotumour describes as a wide range of neoplastic and reactive lesions. One of the rare presentations of these tumors is found in the salpinx. This case report characterizes a thirty six year old woman with a history of left sided abdominal pain for a few months. Further examinations revealed that she had a complex cyst in her left salpinx. The patient had normal levels of tumor markers such as CA125, Alfa Fetoprotein (AFP), and Human Chorionic Gonadotropin (hCG), while other paraclinical test were in normal values Additionaly The patient underwent left salpingectomy by a gynecologist. The pathological diagnosis of the lesion was inflammatory myofibroblastic tumor (IMT). In immunohistochemistry the tumor stains was moderately positive in anaplastic lymphoma kinase (ALK) and also actin positive. Total resection of tumor was performed with no complications and remained disease free during follow up for 40 months. Although Inflammatory Myofibroblastic Tumor (IMT) is benign in nature, but in order to improve the prognosis, this tumor requires low intensity surgical treatment.

Entities:  

Keywords:  Inflammatory myofibroblastic Pseudo tumor; Salpinx

Year:  2014        PMID: 25628846      PMCID: PMC4307108     

Source DB:  PubMed          Journal:  Iran J Cancer Prev        ISSN: 2008-2398


Introduction

Inflammatory pseudotumors describe as a wide range of neoplastic and reactive lesions such as inflammatory myofibroblastic tumor (IMT) and inflammatory pseudotumors of spleen, lymph node and orbit [1]. Inflammatory myofibroblastic tumors arise in a variety of locations such as brain, bone, larynx, stomach, large intestine, small intestine, lung, liver, mediastinum, retroperitoneum and omentum which are mainly diagnosed in the first two decades of life [1-4]. In this case report, a very rare case of IMT arised from the salpinx was identified interestingly we could treat this tumor by a less aggressive method.

Case Report

The patient was a thirty six years old woman with a history of left sided abdominal pain for a few months before treatments. In her abdominal ultrasound examination she had a complex cyst with the diameter of 60×55×40 millimeters in left salpinx. The patient had normal levels of CA125, AFP and HCG and Para-clinical test. The patient underwent left salpingectomy by a gynecologist before referral to our center. The pathological diagnosis of the lesion was inflammatory myofibroblastic tumor. In immunohistochemistry (Figure 1) the tumor stains was moderately positive with anaplastic lymphoma kinase (ALK) and actin positive with. Based on the pathologic findings and according to related reports, we decided completing surgical treatment of the patient as a complete resection of the left adnexa. We recommend only a unilateral resection of left adnexa because of low malignant potential of this special tumor. Fortunately in second look surgery no residual tumor was detected in left adnexa. In post operation CT scan there was no finding of disease in other sites of body. The patient was recommended to have a close follow up after such surgery. A simple cyst of 40 millimeters in the greatest dimension was detected in the ultrasonography of her right ovary after eight months. Since that cyst was asymptomatic and simple, oral contraceptive was prescribed and the patient was also recommended to continue close follow up every 2 months. The lesion was dwindled and fortunately she was disease free in last visit. The time interval between the beginnings of follow up is 58 months till writing this report.
Figure 1

Patients tumor samples and immunohistochemistry staining. 3rd image is taken from an ALK stained specimen.

Discussion

Inflammatory myofibroblastic tumor (in past also called inflammatory pseudotumor) arises from multiple locations. These tumors suggest a chronic inflammatory condition [5]. In 1939 First tumor was observed in lung and named as IMT by Umiker et al. [6] IMT is microscopically characterized by variable combinations of proliferating fibroblasts or myofibroblasts ,inflammatory cells and eosinophils which rarely metastasizes [3, 6-8]. Although it doesn’t show a malignant behavior with its low proliferation rate but is able to grow by infiltration [8]. As half of IMT tumors express anaplastic lymphoma kinase (ALK1) protein, Immunohistochemistry can be helpful in making a correct diagnosis [3, 7]. Several benign fibroblastic lesions such as nodular fasciitis, leiomyoma, desmoid tumor and myofibroblastosis are in differential diagnosis with IMT. ALK expression made distinguish of IMT from these conditions easier [7, 9]. Various pathogenic backgrounds such as infections, neoplastic and autoimmune processes have been reported as initiating factors of IMT but the exact ethology is still unknown [6]. Infection, biliary obstruction, obsesses, primary sclerosing cholangitis, primary biliary cirrhosis, LgG4-related disease, chron diseases, traumatic origin and allergies are suggested as possible causes [5, 10, 11]. Morphologic appearance of IMT is consisting of spindle cells in a myxoid background with the immunprofile of both epithelial and smooth muscle markers [12]. These tumors are classified as tumors of intermediate biological potential by world health organization classification because of tendency for a small risk of metastases and local recurrence [13]. Rearrangements of the ALK locus on chromosome 2p23 in 50% of IMTs support the neoplastic nature of these lesions [1, 14]. Although ALK presentation in IMT is more common in younger people but it’s not restricted to this population. Tumor size and mitotic activity seems not to have correlation with outcomes [1]. Grossly the maximum tumor size is up to 12 cm in diameter. Tumor cut surface is tan or white and often mucoid. IMT may arise in premenopausal women and children [15]. In patient with extensive disease and oncogenic ALK activation, in case of difficult local control, therapeutic ALK inhibition can be helpful [16]. As other studies mentioned, IMT of uterus is very rare occasion [12, 14, 17-19, 20-23]. The previous similar case was a 48 year old woman presented with lower abdominal pain and hydroureteronephrosis reported by Gucer et al. (2005). Rectovaginal examination revealed no uterus and adnexal masses. CT scan revealed 5×4cm mass in cervix which had envaded both parametria. Exploratory laparotomy revealed absence of uteri and adnexa. The patient underwent right salpingo-oophorectomy and subtotal abdominal hysterectomy with complete dissection of pelvic lymph nodes as well as left nephrectomy [24]. Both parametria and Whole cervix were infiltrated by tumor. Tumor characterized by proliferation of fibroblastic-like spindle cells and defuses infiltration of lymphocyts and plasma cells. Immunohistochemical staining showed polyclonal infiltration [24]. There was no sign of recurrent disease in 8 months follow up [24]. In another study Masayuki Shintaku and Akiko Fukushima (2006) reported a 63 year old woman with complaint of lower abdominal distension [14]. Ultrasound and MRI showed a very high intensity on T2-weighted image with a few thin septa showing a low anterior intensity filling the uterus cavity. These septas were enhanced by gadolinium. Needle biopsy showed several small tissue fragments occupied by atypical spindle on myxoid background. As the suggested pathological diagnosis was myxoid leiomyosarcoma, total abdominal hysterectomy and bilateral salpingooophorectomy were done [14]. The patient was free from recurrence for 8 months. The tumor was approximately 11*6*6cm and was protruded from posterior wall into the uterine cavity. More than half of this yellowish white tumor showed granular or diffuse cytoplasmic immunoreactivity for ALK. Tumor cell were arranged in haphazard fashion and lace-like or reticular arrangement occasionally [14].

Conclusion

Although MIT is one of the rarest tumor, because of its nature is very conclusive. Despite of controversial treatments methods such as radiation therapy or chemotherapy, complete resection is also an effective method. Currently this tumor is believed to be a low grade tumor in spite of a benign lesion that requires low intensity and acceptable prognosis. We wish that our experience would be beneficial for treatment of such patients.
  15 in total

Review 1.  Hysteroscopic excision of inflammatory myofibroblastic tumor of the uterus: a case report and brief review.

Authors:  Safak Olgan; Bahadir Saatli; R Emre Okyay; Meral Koyuncuoglu; Erbil Dogan
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-03-24       Impact factor: 2.435

2.  Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.

Authors:  Joseph T Rabban; Charles J Zaloudek; Kris M Shekitka; Fattaneh A Tavassoli
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

3.  Invasive inflammatory pseudotumor of uterine cervix: a case report.

Authors:  Fatih Gücer; Semsi Altaner; Naciye Mülayim; Ozlem Yapicier
Journal:  Gynecol Oncol       Date:  2005-08       Impact factor: 5.482

4.  Pancreatic malignant fibrous histiocytoma, inflammatory myofibroblastic tumor, and inflammatory pseudotumor related to autoimmune pancreatitis: characterization and differential diagnosis.

Authors:  Hiroki Mizukami; Nobuhisa Yajima; Ryuichi Wada; Kazuhito Matsumoto; Motohiro Kojima; Günter Klöppel; Soroku Yagihashi
Journal:  Virchows Arch       Date:  2006-03-15       Impact factor: 4.064

5.  Inflammatory pseudotumor of the uterus.

Authors:  C B Gilks; G P Taylor; P B Clement
Journal:  Int J Gynecol Pathol       Date:  1987       Impact factor: 2.762

Review 6.  Inflammatory myofibroblastic tumours: where are we now?

Authors:  B C Gleason; J L Hornick
Journal:  J Clin Pathol       Date:  2007-10-15       Impact factor: 3.411

7.  Inflammatory myoblastic tumor of the uterus and interleukin-6.

Authors:  Yoichi Azuno; Ken Yaga; Yasuko Suehiro; Shigemi Ariyama; Atsunori Oga
Journal:  Am J Obstet Gynecol       Date:  2003-09       Impact factor: 8.661

8.  Oral inflammatory myofibroblastic tumor: case report and review of literature.

Authors:  Nada O Binmadi; Harold Packman; John C Papadimitriou; Mark Scheper
Journal:  Open Dent J       Date:  2011-04-13

9.  Inflammatory myofibroblastic tumor.

Authors:  Sangeeta Palaskar; Supriya Koshti; Mahesh Maralingannavar; Anirudha Bartake
Journal:  Contemp Clin Dent       Date:  2011-10

10.  Inflammatory myofibroblastic tumor in colon.

Authors:  Eun Young Kim; In Kyu Lee; Yoon Suk Lee; Naery Yang; Dong Jin Chung; Kwang-Il Yim; Jin Il Kim; Seung Taek Oh
Journal:  J Korean Surg Soc       Date:  2011-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.